Status:
UNKNOWN
A Validation Study of the German Autobiographical Memory Interview
Lead Sponsor:
Rheinhessen-Fachklinik Alzey
Collaborating Sponsors:
Johannes Gutenberg University Mainz
Conditions:
Retrograde Amnesia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Electroconvulsive therapy (ECT) is recommended for the treatment of severe depression. But, despite the high remission rates the use of ECT is strongly limited by the social stigma and treatment-emerg...
Detailed Description
To measure retrograde amnesia of autobiographical memory after ECT, various tests were used so far. Currently, the short form of the Autobiographical Memory Interview (AMI-SF) was used most frequently...
Eligibility Criteria
Inclusion
- MDD
- HDRS \> 17
- Age 18-80
- Ability to give informed consent
Exclusion
- Drugs or drug abuse or addictions
- Use of benzodiazepine equivalent to lorazepam\> 1.5 mg per day
- Cognitive impairments
- History of traumatic brain injury
- Relevant organic disease, e.g. Multiple sclerosis, Parkinson's disease
- Bipolar illness, dementia or schizophrenic disorder
- German is not the mother tongue
- Inability to give informed consent
Key Trial Info
Start Date :
August 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04516863
Start Date
August 15 2020
End Date
May 1 2021
Last Update
August 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rheinhessen-Fachklinik Alzey
Alzey, Rhineland-Palatinate, Germany, 55232